Copay assistance fund status, eligibility, and covered drugs — for patient access and billing teams.
Maximum award Up to $10,000 per 12-month grant period · Income ≤500% FPL, adjusted for household size and high-cost living areas · Prescription drug copayments and Medicare Part B insurance premiums for medications including sacrosidase, anti-diarrheals, gas/bloating treatments, and malabsorption treatments.
Published terms from the foundation. Per-patient eligibility and amounts are confirmed at application.
E74.31Drugs whose J-codes this fund matches. Each links to its billing & coding reference.
The foundation's own covered-medication list for this fund (4 drugs). Confirm coverage of your exact NDC at application.
Fund status changes with donations, often without an announcement — confirm directly with the foundation at 800-675-8416, and check the alternatives below.
As of June 10, 2026, the HealthWell Foundation Congenital Sucrase-Isomaltase Deficiency fund is OPEN and accepting applications. Verify at time of service: 800-675-8416.
Up to $10,000 per 12-month grant period. Prescription drug copayments and Medicare Part B insurance premiums for medications including sacrosidase, anti-diarrheals, gas/bloating treatments, and malabsorption treatments.
Household income must be ≤500% FPL, adjusted for household size and high-cost living areas. Treatment must be received in the United States.
Accepted: commercial, medicare, medicaid.